Foyston Gordon & Payne Inc decreased its position in Genpact Limited (NYSE:G - Free Report) by 22.7% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 102,231 shares of the business services provider's stock after selling 29,985 shares during the quarter. Foyston Gordon & Payne Inc owned about 0.06% of Genpact worth $4,008,000 as of its most recent filing with the SEC.
A number of other hedge funds have also recently added to or reduced their stakes in the company. CWM LLC boosted its stake in shares of Genpact by 160.8% during the 2nd quarter. CWM LLC now owns 952 shares of the business services provider's stock worth $31,000 after acquiring an additional 587 shares in the last quarter. Venturi Wealth Management LLC lifted its holdings in Genpact by 74.6% in the 3rd quarter. Venturi Wealth Management LLC now owns 2,623 shares of the business services provider's stock worth $103,000 after purchasing an additional 1,121 shares during the last quarter. GAMMA Investing LLC boosted its position in Genpact by 221.3% during the third quarter. GAMMA Investing LLC now owns 3,329 shares of the business services provider's stock worth $131,000 after purchasing an additional 2,293 shares during the period. Centaurus Financial Inc. acquired a new position in Genpact during the third quarter valued at approximately $159,000. Finally, M&T Bank Corp bought a new position in shares of Genpact in the third quarter valued at approximately $206,000. Institutional investors and hedge funds own 96.03% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities analysts have recently commented on G shares. BMO Capital Markets lifted their price objective on Genpact from $38.00 to $42.00 and gave the stock a "market perform" rating in a research note on Monday, August 12th. Needham & Company LLC upped their price target on Genpact from $42.00 to $55.00 and gave the stock a "buy" rating in a report on Monday, November 11th. Jefferies Financial Group raised their price objective on shares of Genpact from $35.00 to $40.00 and gave the stock a "hold" rating in a research note on Monday, September 9th. JPMorgan Chase & Co. boosted their target price on shares of Genpact from $35.00 to $43.00 and gave the stock a "neutral" rating in a research report on Friday, September 6th. Finally, Robert W. Baird increased their price target on shares of Genpact from $44.00 to $48.00 and gave the company a "neutral" rating in a report on Friday, November 8th. Eight equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Hold" and an average price target of $42.33.
Get Our Latest Stock Report on G
Insider Activity at Genpact
In other news, CEO Balkrishan Kalra sold 9,000 shares of Genpact stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $46.40, for a total transaction of $417,600.00. Following the completion of the sale, the chief executive officer now owns 267,404 shares in the company, valued at $12,407,545.60. The trade was a 3.26 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 2.80% of the stock is currently owned by company insiders.
Genpact Price Performance
Shares of G traded down $0.10 on Tuesday, hitting $44.73. The company's stock had a trading volume of 1,971,702 shares, compared to its average volume of 1,347,332. The company has a market capitalization of $7.89 billion, a PE ratio of 12.32, a PEG ratio of 1.56 and a beta of 1.17. Genpact Limited has a fifty-two week low of $30.23 and a fifty-two week high of $47.98. The company has a 50 day moving average price of $41.95 and a 200 day moving average price of $37.49. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.85 and a quick ratio of 1.85.
Genpact Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, December 23rd. Stockholders of record on Monday, December 9th will be paid a dividend of $0.1525 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $0.61 annualized dividend and a dividend yield of 1.36%. Genpact's dividend payout ratio (DPR) is currently 16.76%.
Genpact Company Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.